ZEN RETARD 300MG (Carbamazepine (300mg))

ZEN Retard 300 mg Extended Release Tablet is a medication classified as an anti-epileptic agent, primarily utilized for the management of epilepsy by preventing specific types of seizures. In addition to its anticonvulsant properties, it is indicated for the relief of severe facial pain associated with trigeminal neuralgia, as well as neuropathic pain due to diabetes, commonly referred to as diabetic neuropathy. It is essential to administer ZEN Retard consistently, either with or without food, at the same time each day to achieve optimal therapeutic outcomes. The prescribing physician will establish the appropriate dosage and frequency tailored to the individual’s health needs, which may be adjusted incrementally based on treatment response. It is crucial to disclose all concurrent medications to your healthcare provider, as various drugs can interact with this one, potentially impacting safety and efficacy. Adherence to the prescribed regimen is vital, even if symptoms improve, since missing doses can lead to seizure recurrence, and discontinuing the medication abruptly may exacerbate the underlying condition. Commonly reported adverse effects include nausea, vomiting, dizziness, fatigue, drowsiness, an unsteady feeling, constipation, a dry mouth, and itching. Vision disturbances and slurred speech may also occur in some individuals. Most of these effects are not severe, but immediate medical attention should be sought if a rash appears, mood disturbances develop, or there are thoughts of self-harm. Prior to initiating ZEN Retard, it is important to inform your doctor of any pre-existing heart conditions, kidney or liver issues, urinary difficulties, or mental health disorders such as depression, as these factors may influence treatment decisions. Regular blood tests may be recommended to monitor health status throughout treatment.